Passionate about the profound difference we can make in lives

Assembly Bio is an ambitious clinical stage biopharmaceutical company with cutting-edge therapeutics capable of improving millions of lives around the world. We are currently focused on the development of two intelligently designed, scientifically novel clinical platforms:

An HBV program

intent on creating a new class of oral therapeutics to finally cure hepatitis B.

Explore our HBV program.

A microbiome program

of potentially life-changing oral live biotherapeutics to transform the treatment of an entire range of underserved diseases linked to the microbiome.

Discover our microbiome program.


Board of Directors

William Ringo

Chairman of the Board, Non-Executive

Anthony Altig

Director

Mark Auerbach

Director

Richard DiMarchi, PhD

Director

Myron Z. Holubiak

Director

Helen S. Kim

Director

Alan J. Lewis, PhD

Director

Sue Mahony, PhD

Director

John McHutchison AO, MD

Chief Executive Officer & President, Director

Derek Small

Director, Senior Advisor, Co-founder

Contact Us

R&D MAIN FACILITY
331 Oyster Point Blvd.
4th Floor
South San Francisco, CA 94080

Get Directions

CORPORATE HEADQUARTERS
11711 North Meridian Street
Suite 310
Carmel, IN 46032

Get Directions

MANUFACTURING
93 Shennecossett Rd

Groton, CT 06340

Get Directions

FOR GENERAL INFORMATION,
PLEASE CONTACT:

833.509.4583
info@assemblybio.com

FOR QUESTIONS ABOUT COLLABORATION
OPPORTUNITIES, PLEASE CONTACT:

BD@assemblybio.com